PL362903A1 - Inhibitory reniny - Google Patents
Inhibitory reninyInfo
- Publication number
- PL362903A1 PL362903A1 PL00362903A PL36290300A PL362903A1 PL 362903 A1 PL362903 A1 PL 362903A1 PL 00362903 A PL00362903 A PL 00362903A PL 36290300 A PL36290300 A PL 36290300A PL 362903 A1 PL362903 A1 PL 362903A1
- Authority
- PL
- Poland
- Prior art keywords
- renin inhibitors
- renin
- inhibitors
- Prior art date
Links
- 239000002461 renin inhibitor Substances 0.000 title 1
- 229940086526 renin-inhibitors Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99108200 | 1999-04-27 | ||
| PCT/EP2000/003597 WO2000064887A1 (en) | 1999-04-27 | 2000-04-20 | Renin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL362903A1 true PL362903A1 (pl) | 2004-11-02 |
Family
ID=8238051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL00362903A PL362903A1 (pl) | 1999-04-27 | 2000-04-20 | Inhibitory reniny |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6197959B1 (pl) |
| EP (1) | EP1180103B1 (pl) |
| JP (1) | JP3602449B2 (pl) |
| KR (1) | KR100476916B1 (pl) |
| CN (1) | CN1323079C (pl) |
| AR (1) | AR018717A1 (pl) |
| AT (1) | ATE363478T1 (pl) |
| AU (1) | AU761392B2 (pl) |
| BR (1) | BR0010076A (pl) |
| CA (1) | CA2370244C (pl) |
| CO (1) | CO5170512A1 (pl) |
| CZ (1) | CZ20013737A3 (pl) |
| DE (1) | DE60035039T2 (pl) |
| ES (1) | ES2286021T3 (pl) |
| HU (1) | HUP0200881A3 (pl) |
| MX (1) | MXPA01010855A (pl) |
| PE (1) | PE20010068A1 (pl) |
| PL (1) | PL362903A1 (pl) |
| SK (1) | SK15172001A3 (pl) |
| TR (1) | TR200103067T2 (pl) |
| WO (1) | WO2000064887A1 (pl) |
| ZA (1) | ZA200108739B (pl) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040214832A1 (en) * | 2003-04-10 | 2004-10-28 | Cuiman Cai | Piperazine derivative renin inhibitors |
| TW200900399A (en) * | 2003-10-01 | 2009-01-01 | Speedel Experimenta Ag | Organic compounds |
| AR045950A1 (es) * | 2003-10-09 | 2005-11-16 | Speedel Experimenta Ag | Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos. |
| CN1906163A (zh) * | 2003-11-26 | 2007-01-31 | 诺瓦提斯公司 | 作为肾素抑制剂的4－苯基哌啶衍生物 |
| AR053406A1 (es) * | 2004-07-09 | 2007-05-09 | Speedel Experimenta Ag | Derivados de piperidina como inhibidores de renina. composiciones farmaceuticas |
| BRPI0516128A (pt) | 2004-10-08 | 2008-08-26 | Novartis Ag | uso de inibidores de renina para a prevenção ou tratamento de disfunção diastólica ou insuficiência cardìca diastólica |
| GB0428526D0 (en) | 2004-12-30 | 2005-02-09 | Novartis Ag | Organic compounds |
| GB0500784D0 (en) * | 2005-01-14 | 2005-02-23 | Novartis Ag | Organic compounds |
| EP1897879A3 (en) * | 2005-03-31 | 2008-06-11 | Speedel Experimenta AG | 2,4,5-substituted piperidines as renin inhibitors |
| EP1707202A1 (de) * | 2005-03-31 | 2006-10-04 | Speedel Experimenta AG | Organische Verbindungen |
| ES2352564T3 (es) * | 2005-03-31 | 2011-02-21 | Novartis Ag | Piperidinas sustituidas. |
| WO2006103275A1 (en) * | 2005-03-31 | 2006-10-05 | Speedel Experimenta Ag | 3,4,5-substituted piperidines as renin inhibitors |
| AR055756A1 (es) * | 2005-03-31 | 2007-09-05 | Speedel Experimenta Ag | Piperidinas sustituidas; procesos de preparacion y su uso como medicamentos |
| GB0508992D0 (en) * | 2005-05-03 | 2005-06-08 | Novartis Ag | Organic compounds |
| US7598390B2 (en) * | 2005-05-11 | 2009-10-06 | Life Technologies Corporation | Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use |
| JP4297972B2 (ja) | 2005-05-27 | 2009-07-15 | アクテリオン ファーマシューティカルズ リミテッド | 新規なピペリジンカルボン酸アミド誘導体 |
| GB0514203D0 (en) * | 2005-07-11 | 2005-08-17 | Novartis Ag | Organic compounds |
| EP1968940B1 (en) * | 2005-12-30 | 2014-04-02 | Novartis AG | 3 , 5-substitued piperidine compounds as renin inhibitors |
| TW200804359A (en) * | 2006-01-19 | 2008-01-16 | Speedel Experimenta Ag | Substituted 4-phenylpiperidines |
| EP1908761A1 (en) * | 2006-10-04 | 2008-04-09 | Speedel Experimenta AG | Organic compounds |
| NZ582098A (en) | 2007-06-25 | 2012-03-30 | Novartis Ag | N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors |
| EP2215088A2 (en) * | 2007-11-02 | 2010-08-11 | Novartis AG | 4,4-disubstituted piperdines as renin inhibitors |
| WO2010129467A1 (en) * | 2009-05-04 | 2010-11-11 | Plexxikon, Inc. | Compounds and methods for inhibition of renin, and indications therefor |
| WO2013045505A1 (en) | 2011-09-28 | 2013-04-04 | Novartis Ag | Biomarkers for raas combination therapy |
| EP2810644A1 (en) | 2013-06-06 | 2014-12-10 | Ferrer Internacional, S.A. | Oral formulation for the treatment of cardiovascular diseases |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR199800409T1 (xx) | 1995-09-07 | 1998-05-21 | F.Hoffmann-La Roche Ag | Kalp ve b�brek yetersizli�inin tedavii�in yeni 4-(oksialkoksifenil)-3-oksi-piperidinler |
-
2000
- 2000-04-04 US US09/542,598 patent/US6197959B1/en not_active Expired - Fee Related
- 2000-04-20 WO PCT/EP2000/003597 patent/WO2000064887A1/en not_active Ceased
- 2000-04-20 BR BR0010076-5A patent/BR0010076A/pt not_active IP Right Cessation
- 2000-04-20 AU AU47501/00A patent/AU761392B2/en not_active Ceased
- 2000-04-20 PL PL00362903A patent/PL362903A1/pl unknown
- 2000-04-20 DE DE60035039T patent/DE60035039T2/de not_active Expired - Fee Related
- 2000-04-20 MX MXPA01010855A patent/MXPA01010855A/es active IP Right Grant
- 2000-04-20 TR TR2001/03067T patent/TR200103067T2/xx unknown
- 2000-04-20 AT AT00929401T patent/ATE363478T1/de not_active IP Right Cessation
- 2000-04-20 CZ CZ20013737A patent/CZ20013737A3/cs unknown
- 2000-04-20 SK SK1517-2001A patent/SK15172001A3/sk unknown
- 2000-04-20 ES ES00929401T patent/ES2286021T3/es not_active Expired - Lifetime
- 2000-04-20 HU HU0200881A patent/HUP0200881A3/hu unknown
- 2000-04-20 EP EP00929401A patent/EP1180103B1/en not_active Expired - Lifetime
- 2000-04-20 CN CNB008067988A patent/CN1323079C/zh not_active Expired - Fee Related
- 2000-04-20 CA CA002370244A patent/CA2370244C/en not_active Expired - Fee Related
- 2000-04-20 KR KR10-2001-7013726A patent/KR100476916B1/ko not_active Expired - Fee Related
- 2000-04-20 JP JP2000614239A patent/JP3602449B2/ja not_active Expired - Fee Related
- 2000-04-24 PE PE2000000377A patent/PE20010068A1/es not_active Application Discontinuation
- 2000-04-25 CO CO00029684A patent/CO5170512A1/es not_active Application Discontinuation
- 2000-04-25 AR ARP000101933A patent/AR018717A1/es active IP Right Grant
-
2001
- 2001-10-23 ZA ZA200108739A patent/ZA200108739B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK15172001A3 (sk) | 2002-06-04 |
| AU761392B2 (en) | 2003-06-05 |
| WO2000064887A1 (en) | 2000-11-02 |
| EP1180103B1 (en) | 2007-05-30 |
| JP2002543072A (ja) | 2002-12-17 |
| DE60035039D1 (de) | 2007-07-12 |
| HUP0200881A2 (en) | 2002-08-28 |
| PE20010068A1 (es) | 2001-01-29 |
| CN1323079C (zh) | 2007-06-27 |
| AU4750100A (en) | 2000-11-10 |
| HUP0200881A3 (en) | 2003-05-28 |
| ATE363478T1 (de) | 2007-06-15 |
| BR0010076A (pt) | 2002-01-15 |
| JP3602449B2 (ja) | 2004-12-15 |
| ES2286021T3 (es) | 2007-12-01 |
| CZ20013737A3 (cs) | 2002-04-17 |
| KR100476916B1 (ko) | 2005-03-17 |
| DE60035039T2 (de) | 2008-02-07 |
| CO5170512A1 (es) | 2002-06-27 |
| CA2370244C (en) | 2007-03-27 |
| ZA200108739B (en) | 2003-01-23 |
| US6197959B1 (en) | 2001-03-06 |
| EP1180103A1 (en) | 2002-02-20 |
| CN1349524A (zh) | 2002-05-15 |
| MXPA01010855A (es) | 2002-05-06 |
| CA2370244A1 (en) | 2000-11-02 |
| AR018717A1 (es) | 2001-11-28 |
| TR200103067T2 (tr) | 2002-05-21 |
| KR20020005017A (ko) | 2002-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG23979A (en) | Renin inhibitors | |
| GB9900416D0 (en) | Inhibitors | |
| PL362903A1 (pl) | Inhibitory reniny | |
| IL148820A0 (en) | Fab i inhibitors | |
| IL146518A0 (en) | Metalloprotease inhibitors | |
| PL350452A1 (en) | Dihetero-substituted metalloprotease inhibitors | |
| EP1235577A4 (en) | PROTEASE INHIBITORS | |
| EP1153022A4 (en) | PROTEASE INHIBITORS | |
| GB9924522D0 (en) | Enzyme inhibitors | |
| EP1232155A4 (en) | PROTEASE INHIBITORS | |
| EP1231921A4 (en) | PROTEASE INHIBITORS | |
| EP1229915A4 (en) | PROTEASE INHIBITORS | |
| EP1229914A4 (en) | PROTEASE INHIBITORS | |
| EP1229912A4 (en) | PROTEASE INHIBITORS | |
| EP1161237A4 (en) | PROTEASE INHIBITORS | |
| EP1351930A4 (en) | PROTEASE INHIBITORS | |
| EP1233771A4 (en) | PROTEASE INHIBITORS | |
| EP1229911A4 (en) | PROTEASE INHIBITORS | |
| EP1173429A4 (en) | PROTEASE INHIBITORS | |
| EP1231923A4 (en) | PROTEASE INHIBITORS | |
| GB2389113B (en) | B-secretase inhibitor | |
| EP1232154A4 (en) | PROTEASE INHIBITORS | |
| EP1231922A4 (en) | PROTEASE INHIBITORS | |
| GB9900413D0 (en) | Inhibitors | |
| GB9929340D0 (en) | Inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |